Trial Profile

Effect of BMS-663068 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fostemsavir (Primary) ; Estradiol/progestogen; Ethinylestradiol/norethisterone
Indications HIV-1 infections
Focus Pharmacokinetics
Sponsors Bristol-Myers Squibb

Most Recent Events

08 Oct 2020 Results applying data from this and other antiretroviral contraceptive studies assessing coadministraion of hormones with Fostemsavir, presented at the 15th International Congress on Drug Therapy and HIV Infection
26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science
02 May 2016 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com